<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>BioPsychoSocial Medicine - Latest articles</title>
		<link>http://www.bpsmedicine.com</link>
		<description>The latest articles from BioPsychoSocial Medicine (ISSN 1751-0759) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.bpsmedicine.com/content/2/1/13"/>			    
            
				    <rdf:li rdf:resource="http://www.bpsmedicine.com/content/2/1/12"/>			    
            
				    <rdf:li rdf:resource="http://www.bpsmedicine.com/content/2/1/11"/>			    
            
				    <rdf:li rdf:resource="http://www.bpsmedicine.com/content/2/1/10"/>			    
            
				    <rdf:li rdf:resource="http://www.bpsmedicine.com/content/2/1/9"/>			    
            
				    <rdf:li rdf:resource="http://www.bpsmedicine.com/content/2/1/8"/>			    
            
				    <rdf:li rdf:resource="http://www.bpsmedicine.com/content/2/1/7"/>			    
            
				    <rdf:li rdf:resource="http://www.bpsmedicine.com/content/2/1/6"/>			    
            
				    <rdf:li rdf:resource="http://www.bpsmedicine.com/content/2/1/5"/>			    
            
				    <rdf:li rdf:resource="http://www.bpsmedicine.com/content/2/1/4"/>			    
            
            </rdf:Seq>
        </items>
    </channel>  
    
		<item rdf:about="http://www.bpsmedicine.com/content/2/1/13">
            
            <title>Application of ecological momentary assessment in stress-related diseases</title>
			<description>Many physical diseases have been reported to be associated with psychosocial factors. In these diseases, assessment relies mainly on subjective symptoms in natural settings. Therefore, it is important to assess symptoms and/or relationships between psychosocial factors and symptoms in natural settings. Symptoms are usually assessed by self-report when patients visit their doctors. However, self-report by recall has an intrinsic problem; "recall bias". Recently, ecological momentary assessment (EMA) has been proposed as a reliable method to assess and record events and subjective symptoms as well as physiological and behavioral variables in natural settings. Although EMA is a useful method to assess stress-related diseases, it has not been fully acknowledged, especially by clinicians. Therefore, the present brief review introduces the application and future direction of EMA for the assessment and intervention for stress-related diseases.</description>
			<link>http://www.bpsmedicine.com/content/2/1/13</link>
			
			 	<dc:creator>Kazuhiro Yoshiuchi, Yoshiharu Yamamoto and Akira Akabayashi</dc:creator>
			
			<dc:source>BioPsychoSocial Medicine 2008, 2:13</dc:source>
			<dc:date>2008-07-11</dc:date>
			<dc:identifier>doi:10.1186/1751-0759-2-13</dc:identifier>
			
			
							
					<prism:publicationName>BioPsychoSocial Medicine</prism:publicationName>
					
			
							
					<prism:issn>1751-0759</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>13</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-11</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.bpsmedicine.com/content/2/1/12">
            
            <title>Effects of antidepressant treatment on heart rate variability in major depression: A quantitative review</title>
			<description>Background:
The literature measuring effects of antidepressant and electroconvulsive therapy (ECT) for major depression on heart rate variability (HRV) in medically well individuals was reviewed.
Methods:
Fourteen studies evaluating HRV were included. Twenty three pre-post or within group comparisons were available. Treatment impact on measures of HRV was pooled over studies. We examined different classes of antidepressants, and for short and long electrocardiogram (ECG) recordings separately.
Results:
Tricyclic antidepressants (TCAs) were associated with declines in most measures of HRV and significant increase in heart rate (HR) in studies with short recording intervals. No significant changes were found for longer recording times.Treatment effects with selective serotonin reuptake inhibitors (SSRIs) were more variable. Short-recording studies revealed a significant decrease in HR and an increase in one HRV measure. In two 24-hour recording studies no significant changes were observed. No relationship between ECT and HRV has been established in the literature. The effects of other drugs are reported.LimitationsFew studies measure the effects of treatment of depression on HRV. Existing studies have generally used very small samples, employing a variety of measurements and methodologies.
Conclusion:
We confirm that TCAs are associated with a large decrease in HRV and increase HR. However, data for SSRIs is not clear. Although the effect of SSRIs on HRV is weaker than for TCAs, evidence shows that SSRIs are associated with a small decrease in HR, and an increase in one measure of HRV. The use of TCAs in depression leads to changes in HRV that are associated with increased risk of mortality.</description>
			<link>http://www.bpsmedicine.com/content/2/1/12</link>
			
			 	<dc:creator>Louis T van Zyl, Takuya Hasegawa and Katsutaro Nagata</dc:creator>
			
			<dc:source>BioPsychoSocial Medicine 2008, 2:12</dc:source>
			<dc:date>2008-06-30</dc:date>
			<dc:identifier>doi:10.1186/1751-0759-2-12</dc:identifier>
			
			
							
					<prism:publicationName>BioPsychoSocial Medicine</prism:publicationName>
					
			
							
					<prism:issn>1751-0759</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>12</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-30</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.bpsmedicine.com/content/2/1/11">
            
            <title>Does psychological status influence clinical outcomes in patients with inflammatory bowel disease (IBD) and other chronic gastroenterological diseases: An observational cohort prospective study</title>
			<description>Background:
Whether there is a temporal relationship between psychological problems and clinical outcomes in patients with diseases of the digestive tract has not been widely researched. Thus, our aims were 1) To observe and compare prospectively clinical outcomes in relation to psychological co-morbidity in patients with inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) and chronic hepatitis C (HCV) and, 2) To test the hypothesis that patients with psychological co-morbidities are less likely to have a satisfactory response to standard treatment at 12 months.
Methods:
Overall, 139 patients were enrolled in this observational cohort prospective study. Over the ensuing year, physical and psychological measures were made at baseline and after 12 months (HADS, SCL90, SF-12 and disease activity measures). A logistic regression was conducted to observe any relationship between baseline characteristics and patients' clinical outcomes after 12 months.
Results:
Overall, there was no relationship between psychological status and quality of life at baseline and relapse at 12 months (p > 0.05). However, patients with inactive disease at baseline were at lower risk of relapse after 12 months (OR = 0.046, CI: 0.012&#8211;0.178). No significant relationship was found between psychological problems such as depression/anxiety and a total number of relapses in the IBD group. However, interestingly, patients with an active disease at baseline tended to have a greater number of relapses (OR = 3.07, CI: 1.650&#8211;5.738) and CD participants were found at lower risk of relapse than UC participants (OR = 0.382, CI: 0.198&#8211;0.736).
Conclusion:
In contrast to previous investigations, this study suggests that there is no temporal relationship between psychological problems at baseline and clinical outcomes over time. Longer and larger prospective studies are needed to better understand this result.</description>
			<link>http://www.bpsmedicine.com/content/2/1/11</link>
			
			 	<dc:creator>Antonina A Mikocka-Walus, Deborah A Turnbull, Nicole T Moulding, Ian G Wilson, Gerald J Holtmann and Jane M Andrews</dc:creator>
			
			<dc:source>BioPsychoSocial Medicine 2008, 2:11</dc:source>
			<dc:date>2008-06-06</dc:date>
			<dc:identifier>doi:10.1186/1751-0759-2-11</dc:identifier>
			
			
							
					<prism:publicationName>BioPsychoSocial Medicine</prism:publicationName>
					
			
							
					<prism:issn>1751-0759</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>11</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-06</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.bpsmedicine.com/content/2/1/10">
            
            <title>Plasma intact fibroblast growth factor 23 levels in women with anorexia nervosa</title>
			<description>Background:
Fibroblast growth factor (FGF)23 is a novel phosphaturic factor associated with inorganic phosphate homeostasis. Previous human studies have shown that serum FGF23 levels increase in response to a high phosphate diet. For anorexia nervosa (AN) patients, inorganic phosphate homeostasis is important in the clinical course, such as in refeeding syndrome. The purpose of this study was to determine plasma levels of intact FGF23 (iFGF23) in restricting-type AN (AN-R) patients, binge-eating/purging-type AN (AN-BP) patients, and healthy controls.
Methods:
The subjects consisted of 6 female AN-R patients, 6 female AN-BP patients, and 11 healthy female controls; both inpatients and outpatients were included. Plasma iFGF23, 1,25-dihydroxyvitamin D (1,25-(OH)2D), and 25-hydroxyvitamin D (25-OHD) levels were measured. Data are presented as the median and the range. A two-tailed Mann-Whitney U-test with Bonferroni correction was used to assess differences among the three groups, and a value of p &lt; 0.017 was considered statistically significant.
Results:
There were no differences between AN-R patients and controls in the iFGF23 and 1,25-(OH)2D levels. In AN-BP patients, the iFGF23 level (41.3 pg/ml; range, 6.1&#8211;155.5 pg/ml) was significantly higher than in controls (3.8 pg/ml; range, not detected-21.3 pg/ml; p = 0.001), and the 1,25-(OH)2D was significantly lower in AN-BP patients (7.0 pg/ml; range, 4.2&#8211;33.7 pg/ml) than in controls (39.7 pg/ml; range, 6.3&#8211;58.5 pg/ml; p = 0.015). No differences in plasma 25-OHD levels were observed among the groups.
Conclusion:
This preliminary study is the first to show that plasma iFGF23 levels are increased in AN-BP patients, and that these elevated plasma FGF23 levels might be related to the decrease in plasma 1,25-(OH)2D levels.</description>
			<link>http://www.bpsmedicine.com/content/2/1/10</link>
			
			 	<dc:creator>Makoto Otani, Yoshiyuki Takimoto, Junko Moriya, Kazuhiro Yoshiuchi and Akira Akabayashi</dc:creator>
			
			<dc:source>BioPsychoSocial Medicine 2008, 2:10</dc:source>
			<dc:date>2008-04-16</dc:date>
			<dc:identifier>doi:10.1186/1751-0759-2-10</dc:identifier>
			
			
							
					<prism:publicationName>BioPsychoSocial Medicine</prism:publicationName>
					
			
							
					<prism:issn>1751-0759</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>10</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-16</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.bpsmedicine.com/content/2/1/9">
            
            <title>Relationship between cognitive appraisals of symptoms and negative mood for subtypes of irritable bowel syndrome</title>
			<description>Background:
The onset and course of irritable bowel syndrome (IBS) are strongly influenced by psychological factors, and treatment often includes cognitive-behavioral therapy. We conducted a study of the relationships between cognitive appraisal of IBS symptoms and negative mood for the subtypes of IBS.MethodThe participants were 1087 college students who completed a set of questionnaires that included the Rome II Modular Questionnaire, Self-reported IBS Questionnaire, Cognitive Appraisal Rating Scale, and the Hospital Anxiety and Depression Scale.
Results:
The participants included 206 individuals with IBS; 61 had diarrhea-predominant IBS (IBSD) and 45 had constipation-predominant IBS (IBSC). The overall IBS group scored higher on anxiety and depression than the control group. The IBSD and IBSC groups each had significantly higher scores for anxiety but did not significantly differ from the control group in scores for depression. There were no significant differences between the IBSD and IBSC groups in their cognitive appraisal of IBS symptoms. For the IBSD group, anxiety was significantly, positively correlated with commitment, effect, and threat, and depression was significantly, negatively correlated with controllability. In contrast, there were no significant correlations between mood and cognitive appraisal for the IBSC group. Multiple regression analyses with abdominal symptoms as dependent variables and cognitive appraisals as independent variables showed that for the IBSD group, abdominal pain was significantly, positively correlated with commitment, and abdominal discomfort was significantly, positively correlated with appraisal of effect and threat. For the IBSC group, abdominal pain and hard stool were significantly, positively correlated with commitment, and abdominal discomfort was significantly, positively correlated with appraisal of effect and threat.
Conclusion:
IBS patients as a general group report high levels of anxiety and depression. However, IBSD and IBSC were both associated only with high anxiety, but not depression, when compared to the non-IBS control group. For the IBSD group, anxiety was associated with cognitive appraisals, but this association was not found for the IBSC group. These groups did not differ in their associated cognitive appraisals, and are similar in terms of the positive relationship between abdominal pain and discomfort and the cognitive appraisals of coping.</description>
			<link>http://www.bpsmedicine.com/content/2/1/9</link>
			
			 	<dc:creator>Nagisa Sugaya and Shinobu Nomura</dc:creator>
			
			<dc:source>BioPsychoSocial Medicine 2008, 2:9</dc:source>
			<dc:date>2008-04-08</dc:date>
			<dc:identifier>doi:10.1186/1751-0759-2-9</dc:identifier>
			
			
							
					<prism:publicationName>BioPsychoSocial Medicine</prism:publicationName>
					
			
							
					<prism:issn>1751-0759</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>9</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-08</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.bpsmedicine.com/content/2/1/8">
            
            <title>Childhood physical abuse in outpatients with psychosomatic symptoms</title>
			<description>Background:
In Japan and Asia, few studies have been done of physical and sexual abuse. This study was aimed to determine whether a history of childhood physical abuse is associated with anxiety, depression and self-injurious behavior in outpatients with psychosomatic symptoms.
Methods:
We divided 564 consecutive new outpatients at the Department of Psychosomatic Medicine of Kyushu University Hospital into two groups: a physically abused group and a non-abused group. Psychological test scores and the prevalence of self-injurious behavior were compared between the two groups.
Results:
A history of childhood physical abuse was reported by patients with depressive disorders(12.7%), anxiety disorders(16.7%), eating disorders (16.3%), pain disorders (10.8%), irritable bowel syndrome (12.5%), and functional dyspepsia(7.5%). In both the patients with depressive disorders and those with anxiety disorders, STAI-I (state anxiety) and STAI-II (trait anxiety) were higher in the abused group than in the non-abused group (p &lt; 0.05).In the patients with depressive disorders, the abused group was younger than the non-abused group (p &lt; 0.05). The prevalence of self-injurious behavior of the patients with depressive disorders, anxiety disorders and pain disorders was higher in the abused groups than in the non-abused groups (p &lt; 0.005).
Conclusion:
A history of childhood physical abuse is associated with psychological distress such as anxiety, depression and self-injurious behavior in outpatients with psychosomatic symptoms. It is important for physicians to consider the history of abuse in the primary care of these patients.</description>
			<link>http://www.bpsmedicine.com/content/2/1/8</link>
			
			 	<dc:creator>Masanori Handa, Hideyuki Nukina, Masako Hosoi and Chiharu Kubo</dc:creator>
			
			<dc:source>BioPsychoSocial Medicine 2008, 2:8</dc:source>
			<dc:date>2008-03-21</dc:date>
			<dc:identifier>doi:10.1186/1751-0759-2-8</dc:identifier>
			
			
							
					<prism:publicationName>BioPsychoSocial Medicine</prism:publicationName>
					
			
							
					<prism:issn>1751-0759</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>8</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-03-21</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.bpsmedicine.com/content/2/1/7">
            
            <title>Symptoms of somatization as a rapid screening tool for mitochondrial dysfunction in depression</title>
			<description>AimsSomatic symptomatology is common in depression, and is often attributed to the Freudian-inspired concept of "somatization". While the same somatic symptoms and depression are common in mitochondrial disease, in cases with concurrent mood symptoms the diagnosis of a mitochondrial disorder and related therapy are typically delayed for many years. A short screening tool that can identify patients with depression at high risk for having underlying mitochondrial dysfunction is presented.
Methods:
Six items of the Karolinska Scales of Personality (KSP) were found to differentiate among 21 chronically-depressed Swedish subjects with low versus normal muscle ATP production rates. A screening tool consisting of the six KSP questions was validated in the relatives of American genetics clinic patients, including in 24 matrilineal relatives in families with maternally inherited mitochondrial disease and in 30 control relatives.
Results:
Among the depressed Swedish patients, the screening tool was positive in 13/14 with low and 1/7 with normal mitochondrial function (P = 0.0003). Applied to the American relatives of patients, the screening tool was positive in 13/24 matrilineal relatives and in 1/30 control relatives (P = 2 &#215; 10-5).
Conclusion:
Our preliminary data suggest that a small number of specific somatic-related questions can be constructed into a valid screening tool for cases at high risk for having a component of energy metabolism in their pathogenesis.</description>
			<link>http://www.bpsmedicine.com/content/2/1/7</link>
			
			 	<dc:creator>Ann Gardner and Richard G Boles</dc:creator>
			
			<dc:source>BioPsychoSocial Medicine 2008, 2:7</dc:source>
			<dc:date>2008-02-22</dc:date>
			<dc:identifier>doi:10.1186/1751-0759-2-7</dc:identifier>
			
			
							
					<prism:publicationName>BioPsychoSocial Medicine</prism:publicationName>
					
			
							
					<prism:issn>1751-0759</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>7</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-02-22</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.bpsmedicine.com/content/2/1/6">
            
            <title>Somatic awareness in the clinical care of patients with body distress symptoms</title>
			<description>The purpose of this paper is to provide primary care physicians and medical specialists with an experiential psychosomatic framework for understanding patients with body distress symptoms. The framework relies on somatic awareness, a normal part of consciousness, to resolve the dualism inherent in conventional multidisciplinary approaches. Somatic awareness represents a guiding healing heuristic which acknowledges the validity of the patient's physical symptoms and uses body sensations to identify the psychological, physiological, and social factors needed for symptom self-regulation. The experiential approach is based on psychobiologic concepts which include bodily distress disorder, central sensitization, dysfunctional breathing, and contextual nature of mood.</description>
			<link>http://www.bpsmedicine.com/content/2/1/6</link>
			
			 	<dc:creator>Donald Bakal, Patrick Coll and Jeffrey Schaefer</dc:creator>
			
			<dc:source>BioPsychoSocial Medicine 2008, 2:6</dc:source>
			<dc:date>2008-02-21</dc:date>
			<dc:identifier>doi:10.1186/1751-0759-2-6</dc:identifier>
			
			
							
					<prism:publicationName>BioPsychoSocial Medicine</prism:publicationName>
					
			
							
					<prism:issn>1751-0759</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>6</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-02-21</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.bpsmedicine.com/content/2/1/5">
            
            <title>Psychological and weight-related characteristics of patients with anorexia nervosa-restricting type who later develop bulimia nervosa</title>
			<description>Background:
Patients with anorexia nervosa-restricting type (AN-R) sometimes develop accompanying bulimic symptoms or the full syndrome of bulimia nervosa (BN). If clinicians could predict who might change into the bulimic sub-type or BN, preventative steps could be taken. Therefore, we investigated anthropometric and psychological factors possibly associated with such changes.MethodAll participants were from a study by the Japanese Genetic Research Group for Eating Disorders. Of 80 patients initially diagnosed with AN-R, 22 changed to the AN-Binge Eating/Purging Type (AN-BP) and 14 to BN for some period of time. The remaining 44 patients remained AN-R only from the onset to the investigation period. Variables compared by ANOVA included anthropometric measures, personality traits such as Multiple Perfectionism Scale scores and Temperament and Character Inventory scores, and Beck Depression Inventory-II scores.
Results:
In comparison with AN-R only patients, those who developed BN had significantly higher current BMI (p &lt; 0.05) and maximum BMI in the past (p &lt; 0.05). They also scored significantly higher for the psychological characteristic of parental criticism (p &lt; 0.05) and lower in self-directedness (p &lt; 0.05), which confirms previous reports, but these differences disappeared when the depression score was used as a co-variant. No significant differences were obtained for personality traits or depression among the AN-R only patients irrespective of their duration of illness.
Conclusion:
The present findings suggest a tendency toward obesity among patients who cross over from AN-R to BN. Low self-directedness and high parental criticism may be associated with the development of BN by patients with AN-R, although the differences may also be associated with depression.</description>
			<link>http://www.bpsmedicine.com/content/2/1/5</link>
			
			 	<dc:creator>Hiroki Nishimura, Gen Komaki, Tetsuya Ando, Toshihiro Nakahara, Takakazu Oka, Keisuke Kawai, Toshihiko Nagata, Aya Nishizono, Yuri Okamoto, Kenjiro Okabe, Masanori Koide, Chikara Yamaguchi, Satoshi Saito, Kazuyoshi Ohkuma, Katsutaro Nagata, Tetsuro Naruo, Masato Takii, Nobuo Kiriike, Toshio Ishikawa and Japanese Genetic Research Group for Eating Disorders</dc:creator>
			
			<dc:source>BioPsychoSocial Medicine 2008, 2:5</dc:source>
			<dc:date>2008-02-12</dc:date>
			<dc:identifier>doi:10.1186/1751-0759-2-5</dc:identifier>
			
			
							
					<prism:publicationName>BioPsychoSocial Medicine</prism:publicationName>
					
			
							
					<prism:issn>1751-0759</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>5</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-02-12</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.bpsmedicine.com/content/2/1/4">
            
            <title>Psychosomatic complaints and sense of coherence among adolescents in a county in Sweden: a cross-sectional school survey</title>
			<description>Background:
Over the last five to ten years there has been an increase in psychosomatic complaints (PSC) in Swedish children. The objective of the study was to examine the relation between PSC and sense of coherence (SOC).
Methods:
A cross-sectional school survey in the county of V&#228;stmanland, Sweden. All 16- and 19-year old adolescents present at school on the day of the survey were asked to complete a questionnaire in their classrooms during a one-lesson hour session under the supervision of their teachers. Totally 3,998 students in both private and public schools, studying in ninth grade elementary school or third grade secondary school participated.
Results:
The results from our study show that there is a statistically significant relation between PSC and SOC among adolescents. It also shows that adolescents with a weak SOC score have more symptoms of PSC.
Conclusion:
Our study indicates that SOC can help the adolescents to choose a coping strategy that is appropriate for the situation and thereby may prevent them from developing PSC. However, additional studies are needed to confirm our findings.</description>
			<link>http://www.bpsmedicine.com/content/2/1/4</link>
			
			 	<dc:creator>Bo Simonsson, Kent W Nilsson, Jerzy Leppert and Vinod K Diwan</dc:creator>
			
			<dc:source>BioPsychoSocial Medicine 2008, 2:4</dc:source>
			<dc:date>2008-02-08</dc:date>
			<dc:identifier>doi:10.1186/1751-0759-2-4</dc:identifier>
			
			
							
					<prism:publicationName>BioPsychoSocial Medicine</prism:publicationName>
					
			
							
					<prism:issn>1751-0759</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>4</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-02-08</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
    <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
